These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 29946775)
21. Isocitrate dehydrogenase status and molecular subclasses of glioma and glioblastoma. Agnihotri S; Aldape KD; Zadeh G Neurosurg Focus; 2014 Dec; 37(6):E13. PubMed ID: 25434382 [TBL] [Abstract][Full Text] [Related]
22. DNA methylation signatures for 2016 WHO classification subtypes of diffuse gliomas. Paul Y; Mondal B; Patil V; Somasundaram K Clin Epigenetics; 2017; 9():32. PubMed ID: 28392842 [TBL] [Abstract][Full Text] [Related]
23. ACTC1 as an invasion and prognosis marker in glioma. Ohtaki S; Wanibuchi M; Kataoka-Sasaki Y; Sasaki M; Oka S; Noshiro S; Akiyama Y; Mikami T; Mikuni N; Kocsis JD; Honmou O J Neurosurg; 2017 Feb; 126(2):467-475. PubMed ID: 27081897 [TBL] [Abstract][Full Text] [Related]
24. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment. van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797 [TBL] [Abstract][Full Text] [Related]
25. Antiangiogenic therapy for high-grade glioma. Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542 [TBL] [Abstract][Full Text] [Related]
26. A Metabolic Inhibitory Cocktail for Grave Cancers: Metformin, Pioglitazone and Lithium Combination in Treatment of Pancreatic Cancer and Glioblastoma Multiforme. Elmaci İ; Altinoz MA Biochem Genet; 2016 Oct; 54(5):573-618. PubMed ID: 27377891 [TBL] [Abstract][Full Text] [Related]
27. Beyond glucose: alternative sources of energy in glioblastoma. Caniglia JL; Jalasutram A; Asuthkar S; Sahagun J; Park S; Ravindra A; Tsung AJ; Guda MR; Velpula KK Theranostics; 2021; 11(5):2048-2057. PubMed ID: 33500708 [TBL] [Abstract][Full Text] [Related]
28. Altered Elemental Distribution in Male Rat Brain Tissue as a Predictor of Glioblastoma Multiforme Growth-Studies Using SR-XRF Microscopy. Planeta K; Setkowicz Z; Czyzycki M; Janik-Olchawa N; Ryszawy D; Janeczko K; Simon R; Baumbach T; Chwiej J Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054889 [TBL] [Abstract][Full Text] [Related]
29. Targeting osteopontin suppresses glioblastoma stem-like cell character and tumorigenicity in vivo. Lamour V; Henry A; Kroonen J; Nokin MJ; von Marschall Z; Fisher LW; Chau TL; Chariot A; Sanson M; Delattre JY; Turtoi A; Peulen O; Rogister B; Castronovo V; Bellahcène A Int J Cancer; 2015 Sep; 137(5):1047-57. PubMed ID: 25620078 [TBL] [Abstract][Full Text] [Related]
30. Glioblastoma heterogeneity and cancer cell plasticity. Friedmann-Morvinski D Crit Rev Oncog; 2014; 19(5):327-36. PubMed ID: 25404148 [TBL] [Abstract][Full Text] [Related]
31. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration. Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830 [TBL] [Abstract][Full Text] [Related]